JA

Jaifer Ali

Active Director Director DIN 08360861
DIN 08360861 First appointment Feb 2019 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Jaifer Ali

Data last updated:

Jaifer Ali is a Director at Hysiac Pharmaceuticals Private Limited (since 2019). The company operates in Home Appliances. Hysiac Pharmaceuticals Private Limited reported revenue of ₹8.7 Lakh (FY 2024).

DIN 08360861
Primary Designation Director
Industry Home Appliances
First Appointment 13 Feb 2019
Oldest Company Age 7 yrs
Largest company Hysiac Pharmaceuticals Private Limited · ₹8.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20192019₹8.7 Lakh (FY 2024)Active

Board colleagues of Jaifer Ali

Directorship timeline

Open interactive timeline →
Hysiac Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jaifer Ali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaifer Ali

Jaifer Ali currently holds 1 directorship: Hysiac Pharmaceuticals Private Limited (Director, since 13 Feb 2019, revenue ₹8.7 Lakh (FY 2024)).

Jaifer Ali was first appointed on 13 Feb 2019 as Director at Hysiac Pharmaceuticals Private Limited.

The current boards of Jaifer Ali's companies include Hashim Panikkaru Thodi (Hysiac Pharmaceuticals Private Limited), Rejina Palappara Kottoth (Hysiac Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available